Mederis Diabetes LLC
Records under this name other than the patents Mederis Diabetes LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 15/986,707 | Peptide Pharmaceuticals Abandoned Abandoned Oct 7, 2020 | Abandoned | Abandoned Oct 7, 2020 | |
| 16/579,799 | Improved Peptide Pharmaceuticals Abandoned Abandoned Dec 12, 2025 | Abandoned | Abandoned Dec 12, 2025 | |
| 16/747,759 | Peptide Pharmaceuticals for Insulin Resistance Abandoned Abandoned Jan 13, 2025 | Abandoned | Abandoned Jan 13, 2025 | |
| 16/826,208 | Improved Peptide Pharmaceuticals for Insulin Resistance Abandoned Abandoned Feb 21, 2026 | Abandoned | Abandoned Feb 21, 2026 | |
| 17/031,583 | Peptide Pharmaceuticals Abandoned Abandoned Sep 25, 2025 | Abandoned | Abandoned Sep 25, 2025 | |
| 18/943,440 | Peptide Pharmaceuticals for Insulin Resistance Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/988,066 | Peptide Pharmaceuticals for Insulin Resistance Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/030,991 | Peptide Pharmaceuticals for Treatment of Nash and Other Disorders Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/322,608 | Peptide Pharmaceuticals Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/396,030 | Polypeptide Pharmaceuticals Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |